ATC Group: S01AE08 Besifloxacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01AE08 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01A Antiinfectives
4 S01AE Fluoroquinolones
5 S01AE08

Active ingredients in S01AE08

Active Ingredient Description
Besifloxacin

Besifloxacin is a fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis.

Related product monographs

Title Information Source Document Type  
BESIVANCE Ophthalmic suspension FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Brazil (BR)

Canada (CA)

Singapore (SG)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.